publication venue for
- H. 17:1195-1210. 2026
- Predicting Δ-9-Tetrahydrocannabinol-Induced Psychoactive and Cognitive Effects: A PBPK-PD Approach to Quantifying Feeling High and Reduced Alertness.. 16:3059-3069. 2025
- In Vitro. 16:1182-1189. 2025
- A Multifunctional Chemical Agent as an Attenuator of Amyloid Burden and Neuroinflammation in Alzheimer's Disease.. 11:1471-1481. 2020
- HSP90 Inhibitor, NVP-AUY922, Improves Myelination in Vitro and Supports the Maintenance of Myelinated Axons in Neuropathic Mice.. 10:2890-2902. 2019
- Untangling the Web: Toxic and Protective Effects of Neuroinflammation and PGE2 Signaling in Alzheimer's Disease.. 7:454-63. 2016
- TREM2 Function in Alzheimer's Disease and Neurodegeneration.. 7:420-7. 2016
- Targeting human central nervous system protein kinases: An isoform selective p38αMAPK inhibitor that attenuates disease progression in Alzheimer's disease mouse models.. 6:666-80. 2015
- Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders.. 5:443-50. 2014
- Long-term lithium treatment reduces glucose metabolism in the cerebellum and hippocampus of nondemented older adults: an [¹⁸F]FDG-PET study.. 5:484-9. 2014
- The modulating effect of mechanical changes in lipid bilayers caused by apoE-containing lipoproteins on Aβ induced membrane disruption.. 2:588-599. 2011
- Quantum dot labeling of butyrylcholinesterase maintains substrate and inhibitor interactions and cell adherence features.. 2:141-50. 2010